A Creative Approach to Third World Markets and to one Start-Up's First Financing
This article was originally published in Start Up
Executive Summary
A new three-way agreement between the University of California, Berkeley (UCB), the Gates Foundation, Amyris Biotechnologies Inc., and the Institute for OneWorld Health (IOWH) showcases one approach to creating affordable drugs for third-world markets that aren't attractive to for-profit companies-with incentives for all participants.